Abstract

The most difficult issue when using tissue engineering products is enabling the ability to store them without losing their restorative capacity. The numbers and viability of mesenchymal stem cells encapsulated in a hydrogel scaffold after cryostorage at −80 °C (by using, individually, two kinds of cryoprotectors—Bambanker and 10% DMSO (Dimethyl sulfoxide) solution) for 3, 6, 9, and 12 months were determined, with subsequent assessment of cell proliferation after 96 h. The analysis of the cellular component was performed using fluorescence microscopy and the two fluorochromes—Hoechst 3334 and NucGreenTM Dead 488. The experimental protocol ensured the preservation of cells in the scaffold structure, retaining both high viability and proliferative activity during storage for 3 months. Longer storage of scaffolds led to their significant changes. Therefore, after 6 months, the proliferative activity of cells decreased. Cryostorage of scaffolds for 9 months led to a decrease in cells’ viability and proliferative activity. As a result of cryostorage of scaffolds for 12 months, a decrease in viability and proliferative activity of cells was observed, as well as pronounced changes in the structure of the hydrogel. The described scaffold cryostorage protocol could become the basis for the development of storage protocols for such tissue engineering products, and for helping to extend the possibilities of their clinical use while accelerating their commercialization.

Highlights

  • The high demand for tissue engineering products is leading to searches for new solutions to meet clinical needs for tissue replacement materials

  • Hybrid hydrogel scaffolds were cultured for 72 h under standard conditions, after which the Hybridin hydrogel scaffoldsshowed were cultured for 72 h under standard conditions, the

  • The protocol described for the cryostorage of a hybrid hydrogel scaffold with encapsulated ASCs allows the scaffold to be retained for three months while maintaining both high cell viability and proliferative activity

Read more

Summary

Introduction

The high demand for tissue engineering products is leading to searches for new solutions to meet clinical needs for tissue replacement materials. One of the most rapidly advancing areas of regenerative medicine is the active development of complex constructs based on scaffolds of various compositions and structures containing cultured cells, and intended to replace damaged and/or lost tissues and organs. Examples of such constructs are the biological equivalents of skin, formed from various matrices and types of cultured cells (keratinocytes and/or fibroblasts). The demand for bioengineering products is constantly growing, providing the incentive to search for new solutions for both scaffold carriers and sources of appropriate cellular material. The easy-availability of the source material is of great importance for practical use

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call